Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) 3-Year Book Growth Rate : 10.90% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Cheng Yi Pharmaceutical Co 3-Year Book Growth Rate?

Zhejiang Cheng Yi Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥3.74.

During the past 12 months, Zhejiang Cheng Yi Pharmaceutical Co's average Book Value per Share Growth Rate was 8.70% per year. During the past 3 years, the average Book Value per Share Growth Rate was 10.90% per year. During the past 5 years, the average Book Value per Share Growth Rate was 12.60% per year. During the past 10 years, the average Book Value per Share Growth Rate was 17.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Zhejiang Cheng Yi Pharmaceutical Co was 26.50% per year. The lowest was 10.90% per year. And the median was 13.85% per year.

Competitive Comparison of Zhejiang Cheng Yi Pharmaceutical Co's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Cheng Yi Pharmaceutical Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Cheng Yi Pharmaceutical Co's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Cheng Yi Pharmaceutical Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Zhejiang Cheng Yi Pharmaceutical Co's 3-Year Book Growth Rate falls into.

Zhejiang Cheng Yi Pharmaceutical Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Zhejiang Cheng Yi Pharmaceutical Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Zhejiang Cheng Yi Pharmaceutical Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

N/A

Address

No. 118, Chemical Road, Dongtou District, Zhejiang Province, Wenzhou, CHN, 325700

Website

http://www.chengyipharma.com

Zhejiang Cheng Yi Pharmaceutical Co Ltd is a pharmaceutical company that produces capsules, injections, tablets, APIs, and pharmaceutical intermediates in China. Its main products include glucosamine hydrochloride raw materials and preparations, torasemide injection and capsules, Gastrodin raw materials, ribavirin and purine raw materials, and so on.

Executives

Ke Ze Hui	Director
Ren Bing Jun	Director
Yan Yi Yi	Director
Ceng Huan Qun	Director
Li Shi Sheng	Director
Qiu Ke Rong	Director
Lv Sun Zhan	senior management
Zhang Gao Qiao	Supervisors
Zhang Zhi Hong	senior management
Mao Li Ping	senior management
Zhuang Xiao Ping	Director
Lin Xin Chen	senior management
Shen Ai Lan	Director
Zhang Fu Fu	Supervisors

Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Headlines

No Headlines